Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00377-6/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsenc=p2ANqtz-_BZiq8xfvOwN8gP1CQFpK7ywqjD2_e-ejEQpTfonbu2diadyMMQLLa-YXoLWCdCnspl3fRFuo4gO3m_hIVfFNqZHBSJg&_hsmi=332487349&utm_content=332424340&utm_source=hs_email